Share
Formulation Development Outsourcing Market Size, Share, and Analysis, By Service (Pre-formulations and Formulation Development), By Formulation (Oral, Injectable, Topical, and Inhaled), By Application (Oncology, Infectious Diseases, Neurology, Hematology, Respiratory, Cardiovascular, and Dermatology), By End-User (Pharmaceutical Industries, Research and Academic Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
Formulation Development Outsourcing Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 7% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 33.9 billion and is projected to reach USD 71.5 billion by the completion of 2034.
Formulation Development Outsourcing refers to the process of hiring external entities or contract research & development firms to manage the development of pharmaceutical or chemical formulations. This outsourcing method enables businesses to utilize the specific expertise of external partners while developing medicine or product compositions. These outsourcing organizations conduct extensive research to discover the ideal combination of ingredients and formulation, which ensures a product's stability and manufacturability. Additionally, companies that outsource formulation development can simplify processes, decrease expenses, and accelerate the time-to-market for new products. Therefore, outsourcing formulation development allows businesses to focus on their core capabilities while benefiting from expertise knowledge and resources for efficient formulation procedures.
Formulation Development Outsourcing Market is projected to reach USD 71.5 billion over the forecast period, due to the rising complexity of drug formulations, combined with high demand for innovative pharmaceuticals and the adoption of affordable strategies by pharmaceutical and biotechnology firms. There has been a considerable increase in outsourcing cooperation as companies are seeking external expertise to improve their formulation methods. Moreover, the global landscape is defined by an abundance of Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) that provide specialized formulation services. Furthermore, strict regulatory needs and rapid improvements in pharmaceutical tech are contributing to the growth of formulation development outsourcing market. Consequently, the market is expected to rise steadily, owing to continuous focus of the industry on research & development activities.
Source: Fatpos Global
Based on Service, the Formulation development outsourcing market is segmented into Pre-formulations and Formulation Development. The formulation development segment is expected to dominate the market owing to its crucial role in navigating the challenges of drug development. With the increasing complications of pharmaceutical formulations, companies are seeking external expertise to navigate the difficult phases of pre-formulation evaluations. Moreover, contract research organizations and contract development & manufacturing organizations are in charge of the optimization process, which is an essential component of formulation development outsourcing. These external partners are armed with modern technologies and function as industry experts in refining the drug components to reach the necessary potency and stability. Besides, external partners serve as auditors and ensures that formulations meet the regulatory standards. Therefore, outsourcing formulation development is a strategic collaboration, which ensures a symphony of success in the pharmaceutical and biotechnological realms.
By Formulation, Formulation Development Outsourcing Market is divided into Oral, Injectable, Topical, and Inhaled. The oral segment is expected to lead the formulation development outsourcing market due to several significant factors. The vast usage of tablets and capsules, which is the most commonly prescribed and consumed dosage forms, substantially contributes to the dominance of this segment. The strong demand for formulation development services for oral medications helps in sustaining a consistent growth trajectory. Moreover, oral drugs have a well-established and uncomplicated regulatory approval process. The simplified regulatory environment accelerates the development timeline, which provides a significant advantage over other dosage forms. This regulatory simplicity enhances the attractiveness of oral segment for outsourcing and reducing uncertainties associated with approvals.
Source: Fatpos Global
Growing Demand for Specialized Expertise will Create Growth Opportunities
Expansion of the formulation development outsourcing market is driven by the growing demand for specialized expertise. The need for expertise increases as the biotechnology and pharmaceutical sectors explore deeper into complicated medication formulations and modern therapeutic techniques. Moreover, contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) are sources of specialized knowledge and advanced technology, which makes them appealing to companies that are looking to improve their internal capabilities. The ability of outsourcing partners to navigate complicated formulation issues positions them as an important contributor to the pharmaceutical development pipeline. This surge in demand reflects the vital significance of specialized skills and resources in accomplishing efficient formulation development.
Increased Focus on R&D Efficiency will Lead to Market Expansion
Increasing emphasis in the pharmaceutical and biotechnology sectors on enhancing R&D efficiency is responsible for the growth of formulation development outsourcing market. Companies strategically depend on outsourcing formulation methods to optimize operational effectiveness, along with reducing costs and accelerate the entry of new products in the market. This efficiency-oriented approach aligns with the wider industry objective of accelerating drug development timelines while upholding strict quality standards. Furthermore, external partners provide essential expertise, which enable companies to allocate resources strategically and focus on their core competencies and research initiatives. Thus, the growth of the market is driven by the acknowledgment that outsourcing formulation development offers a strategic avenue to improve overall R&D efficiency and provide a competitive benefit in the pharmaceutical sector.
Regulatory and Compliance Issues may Impede Industry Growth
Formulation development outsourcing industry has significant obstacles due to regulatory constraints and compliance issues, even with its strong expansion. The pharmaceutical sector operates in a highly regulated setting with strict restrictions that vary by region. Thus, navigating this complex regulatory framework presents significant obstacles for outsourcing organizations and service providers. Additionally, ensuring compliance with diverse regulatory frameworks demands a thorough understanding and continuous adaptation to changing requirements. Thus, effectively addressing these compliance challenges requires vigilance, along with investment in regulatory expertise and smooth communication between outsourcing partners and their clients.
Formulation Development Outsourcing Market is segmented based on regional analysis into five key regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America region stands at the forefront of the formulation development outsourcing market owing to its strong pharmaceutical industry, combined with modern research infrastructure, and high concentration of contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). For instance, Catalent, Inc., a prominent player headquartered in the United States, offers a comprehensive suite of services including formulation development and analytical solutions, which attracts global clients with its expertise and modern facilities. Moreover, North America benefits from a supportive regulatory ecosystem and strong intellectual property protections, which instills confidence in international clients. The skilled workforce in North America and access to advanced technologies further solidify its position. These factors collectively establish North America as a preferred destination for companies which are seeking efficient and high-quality solutions for their formulation development needs.
Source: Fatpos Global
COVID-19 pandemic had a multifaceted impact on the formulation development outsourcing market. Initially, the market witnessed disruptions in global supply chains and restrictions on movement resulted in delays and logistical challenges which affected project timelines and increased costs. Furthermore, the importance of funds to combat the pandemic caused a delay in non-essential research & development efforts, that temporarily lowered the demand for outsourcing services. However, the pandemic highlighted the necessity of agility and resilience in the pharmaceutical sector, which forced corporations to reconsider their outsourcing strategy. Furthermore, demand for formulation expertise grew due to the renewed focus on vaccine and therapeutic research. This rising demand for special services encouraged fast adaptation and innovation in the formulation development outsourcing market to address the evolving needs of the pharmaceutical and biotechnology sectors in combating COVID-19.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2034 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2034 |
|
Historical Period |
2019-2022 |
|
Growth Rate |
CAGR of 7% from 2024-2034 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
By Service |
|
|
By Formulation |
|
|
By Application |
|
|
By End-User |
|
|
By Region |
|
Formulation Development Outsourcing Market size was values at USD 33.9 billion in 2023 and is projected to reach the value of USD 71.5 billion in 2034, exhibiting a CAGR of 7% during the forecast period.
The Formulation Development Outsourcing Market refers to the practice of pharmaceutical and biotechnology companies contracting external organizations or contract research and development (R&D) firms to handle the process of developing formulations for drugs or other products.
Formulation Development segment and the Oral segment accounted for the largest Formulation Development Outsourcing Market share.
Key players in the Formulation Development Outsourcing Market include Catalent, Inc., Lonza Group, Recipharm AB, Evonik Industries AG, Jubilant Life Sciences, Patheon, Cambrex Corporation, Aptuit, Metrics Contract Services, AMRI (Albany Molecular Research Inc.), Curia, Charles River Laboratories, WuXi AppTec, PPD, Inc., Pharmaceutics International, Inc., and Other Prominent Players.
Growing demand for specialized expertise and increased focus on R&D efficiency are the factors driving the formulation development outsourcing market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
